Right ventricular outflow tract obstruction natural history: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Right ventricular outflow tract obstruction}} | {{Right ventricular outflow tract obstruction}} | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
| Line 19: | Line 21: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
Revision as of 16:21, 5 October 2012
|
Right ventricular outflow tract obstruction Microchapters |
|
Classification |
|---|
|
Differentiating Right ventricular outflow tract obstruction from other Diseases |
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Right ventricular outflow tract obstruction natural history On the Web |
|
FDA on Right ventricular outflow tract obstruction natural history |
|
CDC on Right ventricular outflow tract obstruction natural history |
|
Right ventricular outflow tract obstruction natural history in the news |
|
Blogs on Right ventricular outflow tract obstruction natural history |
|
Directions to Hospitals Treating Right ventricular outflow tract obstruction natural history |
|
Risk calculators and risk factors for Right ventricular outflow tract obstruction natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Natural History
Among patients with moderate to severe pulmonic stenosis (PS), the gradient often progressively increases. In patients with mild PS the gradient often remains stable.
Complications
Prognosis
The prognosis among patients with PS who have reached adulthood without right ventricular failure or symptoms is reported to be good with minimal risk of endocarditis, right ventricular failure or death.